AzurRx_Logo_CMYK.jpg
AzurRx BioPharma Adds New Clinical Trial Sites in Ukraine for Phase 2 RESERVOIR Clinical Trial of Niclosamide for the Treatment of COVID-19 Gastrointestinal Infections
August 10, 2021 07:00 ET | AzurRx BioPharma, Inc.
BOCA RATON, Fla., Aug. 10, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (“AzurRx” or the “Company”) (NASDAQ: AZRX), a company specializing in the development of targeted non-systemic,...
AzurRx_Logo_CMYK.jpg
AzurRx BioPharma CEO Issues Letter to Shareholders
January 08, 2021 09:00 ET | AzurRx BioPharma, Inc.
DELRAY BEACH, Fla., Jan. 08, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (“AzurRx” or the “Company”) (NASDAQ: AZRX), a company specializing in the development of targeted non-systemic,...
Metacrine logo.jpg
Metacrine Completes Dosing of First Cohort in Phase 1 Trial of MET409, a Novel Non-Bile Acid FXR Agonist
June 13, 2018 07:30 ET | Metacrine
SAN DIEGO, June 13, 2018 (GLOBE NEWSWIRE) -- Metacrine, Inc., an innovative biotechnology company developing therapies to benefit patients with liver, gastrointestinal and metabolic diseases, today...
Metacrine logo.jpg
Metacrine to Present at Jefferies 2018 Global Healthcare Conference
May 31, 2018 07:30 ET | Metacrine
SAN DIEGO, May 31, 2018 (GLOBE NEWSWIRE) -- Metacrine, Inc., an innovative biotechnology company developing therapies to benefit patients with liver, gastrointestinal and metabolic diseases, today...
Metacrine Broadens M
Metacrine Broadens Management Team with Two Key Hires
April 17, 2018 08:00 ET | Metacrine
SAN DIEGO, April 17, 2018 (GLOBE NEWSWIRE) -- Metacrine, Inc., an innovative biotechnology company developing therapies to benefit patients with liver, gastrointestinal and metabolic diseases, today...
Dr. Schlaberg
New Pathogen-Detection Technology Identifies Infectious Diseases
May 26, 2016 13:51 ET | ARUP Laboratories
SALT LAKE CITY, May 26, 2016 (GLOBE NEWSWIRE) -- ARUP Laboratories Medical Director Robert Schlaberg, MD, Dr Med, MPH, will be the Principal Investigator for a project to help decrease the high...